Breaking News, Collaborations & Alliances

Cumberland Pharmaceuticals Receives Vizient Contract for Vibativ 

The Vibativ 4-Vial Starter Pak is an FDA-approved injectable antibiotic indicated to treat HABP/VABP and complicated skin and skin structure infections.

By: Rachel Klemovitch

Assistant Editor

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, now provides Vibativ (telavancin) 4-Vial Starter Pak through a new contract with Vizient, a provider-driven healthcare performance improvement company. Through this agreement, Vizient members now have increased access to Vibativ’s new 4-vial configuration, which supports flexible treatment initiation in both inpatient and outpatient settings for this potentially life-saving therapy. Vibativ is an FDA-approved injectable a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters